Michael Koontz, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
VA Palo Alto Health Care System Stanford Health Care-Stanford Hospital
University of California Irvine
Medical School
Stanford University
Residency
Stanford University
Fellowship
American Board of Internal Medicine - Oncology
CA State Medical License: 2008 - 2018
American Board of Internal Medicine: Hematology
American Board of Internal Medicine: Medical Oncology
American Board of Internal Medicine: Internal Medicine
Nelarabine neurotoxicity with concurrent intrathecal chemotherapy: Case report and review of literature.
Ngo, D.,Patel, S.,Kim, E. J.,Brar, R.,Koontz, M. Z.; J Oncol Pharm Pract. 2014 Mar 26.
See more >>Risk of therapy-related secondary leukemia in hodgkin lymphoma: the stanford university experience over three generations of clinical trials.
Koontz, M. Z.,Horning, S. J.,Balise, R.,Greenberg, P. L.,Rosenberg, S. A.,Hoppe, R. T.,Advani, R. H.; J Clin Oncol. 2013 Feb 10.
See more >>Neoadjuvant Imatinib for Borderline Resectable GIST.
Koontz, M. Z., Visser, B. M., Kunz, P. L.; J Natl Compr Canc Netw. 2012 Dec 1.
See more >>